Observational studyBMC gastroenterology2026
Long-term clinical course, treatment patterns, and prognosis in pediatric-onset vs. adult-onset IBD: a multicenter retrospective cohort study in Korea.
Observational study in BMC gastroenterology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Mechanistic remodeling and immunoregulatory functions of the B cell-humoral immunity axis in inflammatory bowel disease.Frontiers in immunology · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposeThis study aimed to compare the long-term clinical characteristics, treatment patterns, and prognosis of inflammatory bowel disease (IBD) in patients diagnosed before and after 18 years of age.
methodsA retrospective study was conducted using data from 384 patients with IBD with a disease duration exceeding 10 years across five hospitals. Baseline characteristics, disease status, and treatment patterns were analyzed at diagnosis, 5 years, 10 years, and present.
resultsOf the 384 patients, 84 (21.9%) and 300 (78.1%) were diagnosed before and at or older than the age of 18 years, respectively. Patients diagnosed before 18 years of age more frequently presented with Crohn’s disease (CD) (83.3% vs. 40.0%), whereas ulcerative colitis (UC) was predominant in those diagnosed later (16.7% vs. 60.0%). Younger patients had a significantly higher prevalence of abdominal pain (64.3% vs. 48.7%), malnutrition/weight loss (21.4% vs. 10.7%), and anal fistulas/abscesses (26.2% vs. 5.7%) at the time of diagnosis. Younger patients had more pancolitis-type UC (50% vs. 32.2%) and more perianal diseases in the CD group (51.4% vs. 20.8%). Younger patients initially exhibited higher rates of steroid usage, with a gradual shift towards biologics, such as infliximab. Multivariable Cox regression identified discontinuation of biologic therapy during follow-up as a significant risk factor for disease recurrence.
conclusionOur findings suggest that the age at IBD onset significantly is associated with disease progression and treatment outcomes, underscoring the need for age-tailored management strategies in long-term IBD care.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.